Skip to main content
Top
Published in: Archives of Virology 1/2019

01-01-2019 | Brief Report

Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract

Authors: Vasily A. Evseenko, Natalia P. Kolosova, Anderi S. Gudymo, Semion V. Maltsev, Julia A. Bulanovich, Nataliya I. Goncharova, Natalia V. Danilchenko, Vasiliy Y. Marchenko, Ivan M. Susloparov, Alexander B. Ryzhikov

Published in: Archives of Virology | Issue 1/2019

Login to get access

Abstract

Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.
Appendix
Available only for authorised users
Literature
1.
go back to reference Quan FS, Compans RW, Kang SM (2012) Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. Vaccine 30(2):180–188CrossRefPubMed Quan FS, Compans RW, Kang SM (2012) Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. Vaccine 30(2):180–188CrossRefPubMed
3.
go back to reference Pfaar O, Mullol J, Anders C, Hörmann K, Klimek L (2012) Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: a randomized double-blind, placebo-controlled trial. Rhinology 50(1):37–44PubMed Pfaar O, Mullol J, Anders C, Hörmann K, Klimek L (2012) Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: a randomized double-blind, placebo-controlled trial. Rhinology 50(1):37–44PubMed
4.
go back to reference Gudymo AS, Maltsev SV, Evseenko VA, Danilchenko NV, Marchenko VY, Durymanov AG et al (2017) Cyclamen europaeum (Cyclamen purpurascens) extract as adjuvant for nasal immunization of mice with influenza antigens. BIOprep Prev Diagn Treat 17(4):233–239 Gudymo AS, Maltsev SV, Evseenko VA, Danilchenko NV, Marchenko VY, Durymanov AG et al (2017) Cyclamen europaeum (Cyclamen purpurascens) extract as adjuvant for nasal immunization of mice with influenza antigens. BIOprep Prev Diagn Treat 17(4):233–239
Metadata
Title
Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract
Authors
Vasily A. Evseenko
Natalia P. Kolosova
Anderi S. Gudymo
Semion V. Maltsev
Julia A. Bulanovich
Nataliya I. Goncharova
Natalia V. Danilchenko
Vasiliy Y. Marchenko
Ivan M. Susloparov
Alexander B. Ryzhikov
Publication date
01-01-2019
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 1/2019
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-4023-3

Other articles of this Issue 1/2019

Archives of Virology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine